INNOVA CAPTAB

Corporate Governance

Company Policies

Committee Constitution

Committee Constitution [Download]

Material Creditors

Material Contracts for the Offer

Material documents

1. Certified copies of the Memorandum of Association and Articles of Association [Download]
2. Certificate of incorporation dated January 3, 2005. [Download]
3. Fresh certificate of incorporation consequent to change of our name to ‘Innova Captab Private Limited’ dated February 2, 2010. [Download]
4. Fresh certificate of incorporation consequent upon conversion to public limited company dated July 26,2018. [Download]
5. Resolution of the Board of Directors and the Shareholders of our Company dated June 19, 2022, and June 24, 2022, respectively in relation to the Offer and other related matters. [Download]
6. Resolution of the Board of Directors of our Company dated June 27, 2022, approving the Draft Red Herring Prospectus. [Download]
7. Resolution of the Board of Directors of our Company dated December 14, 2023, approving this Red Herring Prospectus. [Download]
8. Consent letters from the Selling Shareholders in relation to the Offer for Sale. [Download]
9. Consent dated December 1, 2023 from CRISIL [Download]
10. Industry report titled ‘Assessment of Indian pharmaceutical and CDMO market’, dated October 2023, prepared by CRISIL MI&A. [Download]
11. Consent from the Statutory Auditors namely, B S R & Co. LLP, [Download]
12. Consent letter dated December 14, 2023 from Parashar & Co., Chartered Engineer, [Download]
13. Consent letter dated December 14, 2023, from N B T and Co, Chartered Accountants, [Download]
14. Consent letter dated December 14, 2023, from N. Bhasin & Associates, [Download]
15. Report issued by the Statutory Auditors dated December 14, 2023, on the statement of possible special tax benefits available to our Company, our Shareholders and our Material Subsidiaries. [Download]
16. Agreement to sell business dated March 31, 2021, entered into between our Company and Innova Partnership. [Download]
17. Share purchase agreement dated December 31, 2021, entered into between our Company, previous shareholders of Univentis Medicare Limited and Univentis Medicare Limited. [Download]
18. Share subscription agreement dated July 13, 2022, entered into by our Company with UTI Multi Opportunities Fund I,along with the agreement dated December 1, 2023. [Download]
19. Share subscription agreement dated December 1, 2023, entered into by our Company with 360 One Special Opportunities Fund – Series 9, 360 One Special Opportunities Fund – Series 10. [Download]
20. Deeds of guarantees in connection with the guarantees as set out under “History and Certain Corporate Matters – Guarantees given by our Promoter Selling Shareholders. [Download]
21. Copies of annual reports of our Company for the preceding three Fiscals. [Download]
22. Consent letter. [Download]
23. Tripartite agreement dated April 6, 2022, amongst our Company, NSDL and the Registrar to the Offer. [Download]
24. Tripartite agreement dated March 28, 2022, amongst our Company, CDSL and the Registrar to the Offer. [Download]
25 Due diligence certificate dated June 28, 2022, addressed to SEBI from the BRLMs. [Download]
26. In-principle listing approvals dated September 16, 2022, and September 15, 2022, issued by BSE and NSE,respectively. [Download]
27. SEBI observation letter dated January 11, 2023, and the in-seriatim reply of the BRLMs dated December 5,2023. [Download]

Investor Relations

Financial Information

Draft Red Herring Prospectus (DRHP)

Red Herring Prospectus (RHP)

Prospectus

Corporate Governance

Disclosure under regulation 46 of SEBI

Industry Report

Earning Call